0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Cardiopulmonary Machine Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-27I8048
Home | Market Reports | Health| Medical Devices & Equipment
Global Artificial Cardiopulmonary Machine Market Insights Forecast to 2028
BUY CHAPTERS

Global Artificial Cardiopulmonary Machine Market Research Report 2025

Code: QYRE-Auto-27I8048
Report
September 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artificial Cardiopulmonary Machine Market

The global market for Artificial Cardiopulmonary Machine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Artificial Cardiopulmonary Machine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Artificial Cardiopulmonary Machine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Artificial Cardiopulmonary Machine include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Artificial Cardiopulmonary Machine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Cardiopulmonary Machine.
The Artificial Cardiopulmonary Machine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Cardiopulmonary Machine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Cardiopulmonary Machine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Artificial Cardiopulmonary Machine Market Report

Report Metric Details
Report Name Artificial Cardiopulmonary Machine Market
Segment by Type
  • Single Roller Pump HLM
  • Double Roller Pump HLM
Segment by Application
  • Cardiac Surgery
  • Lung Transplant Operation
  • Acute Respiratory Failure Treatment
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Artificial Cardiopulmonary Machine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Artificial Cardiopulmonary Machine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Artificial Cardiopulmonary Machine Market report?

Ans: The main players in the Artificial Cardiopulmonary Machine Market are LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical

What are the Application segmentation covered in the Artificial Cardiopulmonary Machine Market report?

Ans: The Applications covered in the Artificial Cardiopulmonary Machine Market report are Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Others

What are the Type segmentation covered in the Artificial Cardiopulmonary Machine Market report?

Ans: The Types covered in the Artificial Cardiopulmonary Machine Market report are Single Roller Pump HLM, Double Roller Pump HLM

1 Artificial Cardiopulmonary Machine Market Overview
1.1 Product Definition
1.2 Artificial Cardiopulmonary Machine by Type
1.2.1 Global Artificial Cardiopulmonary Machine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Single Roller Pump HLM
1.2.3 Double Roller Pump HLM
1.3 Artificial Cardiopulmonary Machine by Application
1.3.1 Global Artificial Cardiopulmonary Machine Market Value by Application (2024 VS 2031)
1.3.2 Cardiac Surgery
1.3.3 Lung Transplant Operation
1.3.4 Acute Respiratory Failure Treatment
1.3.5 Others
1.4 Global Artificial Cardiopulmonary Machine Market Size Estimates and Forecasts
1.4.1 Global Artificial Cardiopulmonary Machine Revenue 2020-2031
1.4.2 Global Artificial Cardiopulmonary Machine Sales 2020-2031
1.4.3 Global Artificial Cardiopulmonary Machine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Artificial Cardiopulmonary Machine Market Competition by Manufacturers
2.1 Global Artificial Cardiopulmonary Machine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Artificial Cardiopulmonary Machine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Artificial Cardiopulmonary Machine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Cardiopulmonary Machine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Cardiopulmonary Machine, Product Type & Application
2.7 Global Key Manufacturers of Artificial Cardiopulmonary Machine, Date of Enter into This Industry
2.8 Global Artificial Cardiopulmonary Machine Market Competitive Situation and Trends
2.8.1 Global Artificial Cardiopulmonary Machine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Artificial Cardiopulmonary Machine Players Market Share by Revenue
2.8.3 Global Artificial Cardiopulmonary Machine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Artificial Cardiopulmonary Machine Market Scenario by Region
3.1 Global Artificial Cardiopulmonary Machine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Artificial Cardiopulmonary Machine Sales by Region: 2020-2031
3.2.1 Global Artificial Cardiopulmonary Machine Sales by Region: 2020-2025
3.2.2 Global Artificial Cardiopulmonary Machine Sales by Region: 2026-2031
3.3 Global Artificial Cardiopulmonary Machine Revenue by Region: 2020-2031
3.3.1 Global Artificial Cardiopulmonary Machine Revenue by Region: 2020-2025
3.3.2 Global Artificial Cardiopulmonary Machine Revenue by Region: 2026-2031
3.4 North America Artificial Cardiopulmonary Machine Market Facts & Figures by Country
3.4.1 North America Artificial Cardiopulmonary Machine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Artificial Cardiopulmonary Machine Sales by Country (2020-2031)
3.4.3 North America Artificial Cardiopulmonary Machine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Artificial Cardiopulmonary Machine Market Facts & Figures by Country
3.5.1 Europe Artificial Cardiopulmonary Machine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Artificial Cardiopulmonary Machine Sales by Country (2020-2031)
3.5.3 Europe Artificial Cardiopulmonary Machine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Cardiopulmonary Machine Market Facts & Figures by Region
3.6.1 Asia Pacific Artificial Cardiopulmonary Machine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Artificial Cardiopulmonary Machine Sales by Region (2020-2031)
3.6.3 Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Artificial Cardiopulmonary Machine Market Facts & Figures by Country
3.7.1 Latin America Artificial Cardiopulmonary Machine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Artificial Cardiopulmonary Machine Sales by Country (2020-2031)
3.7.3 Latin America Artificial Cardiopulmonary Machine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Cardiopulmonary Machine Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Cardiopulmonary Machine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Artificial Cardiopulmonary Machine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artificial Cardiopulmonary Machine Sales by Type (2020-2031)
4.1.1 Global Artificial Cardiopulmonary Machine Sales by Type (2020-2025)
4.1.2 Global Artificial Cardiopulmonary Machine Sales by Type (2026-2031)
4.1.3 Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2020-2031)
4.2 Global Artificial Cardiopulmonary Machine Revenue by Type (2020-2031)
4.2.1 Global Artificial Cardiopulmonary Machine Revenue by Type (2020-2025)
4.2.2 Global Artificial Cardiopulmonary Machine Revenue by Type (2026-2031)
4.2.3 Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2020-2031)
4.3 Global Artificial Cardiopulmonary Machine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Artificial Cardiopulmonary Machine Sales by Application (2020-2031)
5.1.1 Global Artificial Cardiopulmonary Machine Sales by Application (2020-2025)
5.1.2 Global Artificial Cardiopulmonary Machine Sales by Application (2026-2031)
5.1.3 Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2020-2031)
5.2 Global Artificial Cardiopulmonary Machine Revenue by Application (2020-2031)
5.2.1 Global Artificial Cardiopulmonary Machine Revenue by Application (2020-2025)
5.2.2 Global Artificial Cardiopulmonary Machine Revenue by Application (2026-2031)
5.2.3 Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2020-2031)
5.3 Global Artificial Cardiopulmonary Machine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 LivaNova (Sorin)
6.1.1 LivaNova (Sorin) Company Information
6.1.2 LivaNova (Sorin) Description and Business Overview
6.1.3 LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 LivaNova (Sorin) Artificial Cardiopulmonary Machine Product Portfolio
6.1.5 LivaNova (Sorin) Recent Developments/Updates
6.2 Getinge (Maquet)
6.2.1 Getinge (Maquet) Company Information
6.2.2 Getinge (Maquet) Description and Business Overview
6.2.3 Getinge (Maquet) Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Getinge (Maquet) Artificial Cardiopulmonary Machine Product Portfolio
6.2.5 Getinge (Maquet) Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Medtronic Artificial Cardiopulmonary Machine Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Terumo CV Group
6.4.1 Terumo CV Group Company Information
6.4.2 Terumo CV Group Description and Business Overview
6.4.3 Terumo CV Group Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Terumo CV Group Artificial Cardiopulmonary Machine Product Portfolio
6.4.5 Terumo CV Group Recent Developments/Updates
6.5 Braile Biomedica
6.5.1 Braile Biomedica Company Information
6.5.2 Braile Biomedica Description and Business Overview
6.5.3 Braile Biomedica Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Braile Biomedica Artificial Cardiopulmonary Machine Product Portfolio
6.5.5 Braile Biomedica Recent Developments/Updates
6.6 Tianjin Medical
6.6.1 Tianjin Medical Company Information
6.6.2 Tianjin Medical Description and Business Overview
6.6.3 Tianjin Medical Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Tianjin Medical Artificial Cardiopulmonary Machine Product Portfolio
6.6.5 Tianjin Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Cardiopulmonary Machine Industry Chain Analysis
7.2 Artificial Cardiopulmonary Machine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Cardiopulmonary Machine Production Mode & Process Analysis
7.4 Artificial Cardiopulmonary Machine Sales and Marketing
7.4.1 Artificial Cardiopulmonary Machine Sales Channels
7.4.2 Artificial Cardiopulmonary Machine Distributors
7.5 Artificial Cardiopulmonary Machine Customer Analysis
8 Artificial Cardiopulmonary Machine Market Dynamics
8.1 Artificial Cardiopulmonary Machine Industry Trends
8.2 Artificial Cardiopulmonary Machine Market Drivers
8.3 Artificial Cardiopulmonary Machine Market Challenges
8.4 Artificial Cardiopulmonary Machine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Artificial Cardiopulmonary Machine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Artificial Cardiopulmonary Machine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Artificial Cardiopulmonary Machine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Artificial Cardiopulmonary Machine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Artificial Cardiopulmonary Machine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Artificial Cardiopulmonary Machine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Artificial Cardiopulmonary Machine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Artificial Cardiopulmonary Machine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Artificial Cardiopulmonary Machine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Artificial Cardiopulmonary Machine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Artificial Cardiopulmonary Machine, Product Type & Application
 Table 12. Global Key Manufacturers of Artificial Cardiopulmonary Machine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Artificial Cardiopulmonary Machine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Cardiopulmonary Machine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Artificial Cardiopulmonary Machine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Artificial Cardiopulmonary Machine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Artificial Cardiopulmonary Machine Sales Market Share by Region (2020-2025)
 Table 19. Global Artificial Cardiopulmonary Machine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Artificial Cardiopulmonary Machine Sales Market Share by Region (2026-2031)
 Table 21. Global Artificial Cardiopulmonary Machine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Artificial Cardiopulmonary Machine Revenue Market Share by Region (2020-2025)
 Table 23. Global Artificial Cardiopulmonary Machine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Artificial Cardiopulmonary Machine Revenue Market Share by Region (2026-2031)
 Table 25. North America Artificial Cardiopulmonary Machine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Artificial Cardiopulmonary Machine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Artificial Cardiopulmonary Machine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Artificial Cardiopulmonary Machine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Artificial Cardiopulmonary Machine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Artificial Cardiopulmonary Machine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Artificial Cardiopulmonary Machine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Artificial Cardiopulmonary Machine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Artificial Cardiopulmonary Machine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Artificial Cardiopulmonary Machine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Artificial Cardiopulmonary Machine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Artificial Cardiopulmonary Machine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Artificial Cardiopulmonary Machine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Artificial Cardiopulmonary Machine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Artificial Cardiopulmonary Machine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Artificial Cardiopulmonary Machine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Artificial Cardiopulmonary Machine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Artificial Cardiopulmonary Machine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Artificial Cardiopulmonary Machine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Artificial Cardiopulmonary Machine Sales (K Units) by Type (2020-2025)
 Table 51. Global Artificial Cardiopulmonary Machine Sales (K Units) by Type (2026-2031)
 Table 52. Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2020-2025)
 Table 53. Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2026-2031)
 Table 54. Global Artificial Cardiopulmonary Machine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Artificial Cardiopulmonary Machine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2020-2025)
 Table 57. Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2026-2031)
 Table 58. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Artificial Cardiopulmonary Machine Sales (K Units) by Application (2020-2025)
 Table 61. Global Artificial Cardiopulmonary Machine Sales (K Units) by Application (2026-2031)
 Table 62. Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2020-2025)
 Table 63. Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2026-2031)
 Table 64. Global Artificial Cardiopulmonary Machine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Artificial Cardiopulmonary Machine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2020-2025)
 Table 67. Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2026-2031)
 Table 68. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Application (2026-2031)
 Table 70. LivaNova (Sorin) Company Information
 Table 71. LivaNova (Sorin) Description and Business Overview
 Table 72. LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. LivaNova (Sorin) Artificial Cardiopulmonary Machine Product
 Table 74. LivaNova (Sorin) Recent Developments/Updates
 Table 75. Getinge (Maquet) Company Information
 Table 76. Getinge (Maquet) Description and Business Overview
 Table 77. Getinge (Maquet) Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Getinge (Maquet) Artificial Cardiopulmonary Machine Product
 Table 79. Getinge (Maquet) Recent Developments/Updates
 Table 80. Medtronic Company Information
 Table 81. Medtronic Description and Business Overview
 Table 82. Medtronic Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Medtronic Artificial Cardiopulmonary Machine Product
 Table 84. Medtronic Recent Developments/Updates
 Table 85. Terumo CV Group Company Information
 Table 86. Terumo CV Group Description and Business Overview
 Table 87. Terumo CV Group Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Terumo CV Group Artificial Cardiopulmonary Machine Product
 Table 89. Terumo CV Group Recent Developments/Updates
 Table 90. Braile Biomedica Company Information
 Table 91. Braile Biomedica Description and Business Overview
 Table 92. Braile Biomedica Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Braile Biomedica Artificial Cardiopulmonary Machine Product
 Table 94. Braile Biomedica Recent Developments/Updates
 Table 95. Tianjin Medical Company Information
 Table 96. Tianjin Medical Description and Business Overview
 Table 97. Tianjin Medical Artificial Cardiopulmonary Machine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Tianjin Medical Artificial Cardiopulmonary Machine Product
 Table 99. Tianjin Medical Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Artificial Cardiopulmonary Machine Distributors List
 Table 103. Artificial Cardiopulmonary Machine Customers List
 Table 104. Artificial Cardiopulmonary Machine Market Trends
 Table 105. Artificial Cardiopulmonary Machine Market Drivers
 Table 106. Artificial Cardiopulmonary Machine Market Challenges
 Table 107. Artificial Cardiopulmonary Machine Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Artificial Cardiopulmonary Machine
 Figure 2. Global Artificial Cardiopulmonary Machine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Artificial Cardiopulmonary Machine Market Share by Type: 2024 & 2031
 Figure 4. Single Roller Pump HLM Product Picture
 Figure 5. Double Roller Pump HLM Product Picture
 Figure 6. Global Artificial Cardiopulmonary Machine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Artificial Cardiopulmonary Machine Market Share by Application: 2024 & 2031
 Figure 8. Cardiac Surgery
 Figure 9. Lung Transplant Operation
 Figure 10. Acute Respiratory Failure Treatment
 Figure 11. Others
 Figure 12. Global Artificial Cardiopulmonary Machine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Artificial Cardiopulmonary Machine Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Artificial Cardiopulmonary Machine Sales (2020-2031) & (K Units)
 Figure 15. Global Artificial Cardiopulmonary Machine Average Price (US$/Unit) & (2020-2031)
 Figure 16. Artificial Cardiopulmonary Machine Report Years Considered
 Figure 17. Artificial Cardiopulmonary Machine Sales Share by Manufacturers in 2024
 Figure 18. Global Artificial Cardiopulmonary Machine Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Artificial Cardiopulmonary Machine Players: Market Share by Revenue in Artificial Cardiopulmonary Machine in 2024
 Figure 20. Artificial Cardiopulmonary Machine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Artificial Cardiopulmonary Machine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Artificial Cardiopulmonary Machine Sales Market Share by Country (2020-2031)
 Figure 23. North America Artificial Cardiopulmonary Machine Revenue Market Share by Country (2020-2031)
 Figure 24. United States Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Artificial Cardiopulmonary Machine Sales Market Share by Country (2020-2031)
 Figure 27. Europe Artificial Cardiopulmonary Machine Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Artificial Cardiopulmonary Machine Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Artificial Cardiopulmonary Machine Revenue Market Share by Region (2020-2031)
 Figure 35. China Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Artificial Cardiopulmonary Machine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Artificial Cardiopulmonary Machine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Artificial Cardiopulmonary Machine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Artificial Cardiopulmonary Machine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Artificial Cardiopulmonary Machine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Artificial Cardiopulmonary Machine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Artificial Cardiopulmonary Machine by Type (2020-2031)
 Figure 56. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Artificial Cardiopulmonary Machine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Artificial Cardiopulmonary Machine by Application (2020-2031)
 Figure 59. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Application (2020-2031)
 Figure 60. Artificial Cardiopulmonary Machine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart